EGFR and neoplasm: To verify whether the targeting contrast agents could significantly increase specificity in MR tumor imaging, in vitro contrast-enhanced MRI with EBP-Gd-DO3A and EBP-(Gd-DO3A)3 was conducted in different EGFR-expressing cells using Gadovist as a control.